SG Americas Securities
ABMD

SG Americas Securities’s Abiomed Inc ABMD Stock Holding History

SG Americas Securities’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,128
Closed -$523K – 3487
2022
Q3 		$523K Sell
2,128
-76
-3% -$20.5K 0.01% 1514
2022
Q2 		$546K Buy
2,204
+1,339
+155% +$361K 0.01% 1890
2022
Q1 		$287K Sell
865
-347
-29% -$107K ﹤0.01% 2222
2021
Q4 		$435K Sell
1,212
-1,793
-60% -$606K ﹤0.01% 2242
2021
Q3 		$978K Sell
3,005
-27,648
-90% -$9.37M ﹤0.01% 1928
2021
Q2 		$9.57M Buy
30,653
+29,299
+2,164% +$8.99M 0.04% 365
2021
Q1 		$432K Sell
1,354
-22,504
-94% -$7.2M ﹤0.01% 2118
2020
Q4 		$7.74M Buy
23,858
+22,097
+1,255% +$6.11M 0.04% 331
2020
Q3 		$488K Sell
1,761
-4,855
-73% -$1.4M ﹤0.01% 1651
2020
Q2 		$1.6M Buy
6,616
+2,697
+69% +$542K 0.01% 991
2020
Q1 		$569K Buy
3,919
+2,578
+192% +$428K 0.01% 1745
2019
Q4 		$229K Sell
1,341
-6,803
-84% -$1.26M ﹤0.01% 2386
2019
Q3 		$1.45M Buy
8,144
+958
+13% +$207K 0.01% 1178
2019
Q2 		$1.87M Sell
7,186
-8,651
-55% -$2.3M 0.01% 1062
2019
Q1 		$4.52M Buy
15,837
+9,415
+147% +$3.13M 0.04% 455
2018
Q4 		$2.09M Sell
6,422
-199
-3% -$69.1K 0.02% 853
2018
Q3 		$2.98M Sell
6,621
-4,452
-40% -$1.75M 0.02% 873
2018
Q2 		$4.53M Buy
11,073
+1,755
+19% +$636K 0.04% 475
2018
Q1 		$2.71M Sell
9,318
-14,760
-61% -$3.74M 0.02% 705
2017
Q4 		$4.51M Buy
24,078
+19,776
+460% +$3.69M 0.04% 425
2017
Q3 		$725K Sell
4,302
-13,866
-76% -$2.1M 0.01% 1519
2017
Q2 		$2.6M Buy
18,168
+2,534
+16% +$341K 0.02% 725
2017
Q1 		$1.96M Buy
15,634
+10,201
+188% +$1.18M 0.02% 906
2016
Q4 		$612K Buy
5,433
+2,975
+121% +$345K 0.01% 1578
2016
Q3 		$316K Sell
2,458
-1,141
-32% -$137K ﹤0.01% 2123
2016
Q2 		$393K Sell
3,599
-6,252
-63% -$622K ﹤0.01% 1833
2016
Q1 		$934K Buy
+9,851
New +$832K 0.01% 1362
2015
Q4 		– Sell
-4,135
Closed -$384K – 3058
2015
Q3 		$384K Buy
+4,135
New +$364K ﹤0.01% 1154
2015
Q1 		– Sell
-8,792
Closed -$335K – 3174
2014
Q4 		$335K Buy
+8,792
New +$277K ﹤0.01% 1965
2013
Q4 		– Sell
-7,307
Closed -$139K – 3110
2013
Q3 		$139K Buy
+7,307
New +$167K ﹤0.01% 2446

Other funds holding ABMD

Teachers Retirement System of the State of Kentucky
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return
Blue Trust Inc
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
Huntington National Bank
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

SG Americas Securities's ABMD Position: Q4 2022 in Review

SG Americas Securities sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,128 shares — an estimated $523K sold.

SG Americas Securities first reported a position in ABMD in Q3 2013 and held it in 30 quarters. The position peaked at $9.57M in Q2 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • SG Americas Securities reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • SG Americas Securities sold 2,128 Abiomed Inc shares in Q4 2022, an estimated $523K.
  • SG Americas Securities first reported a position in Abiomed Inc in Q3 2013 and held it in 30 quarters.
  • SG Americas Securities's Abiomed Inc position peaked at $9.57M in Q2 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on SG Americas Securities's 13F filing for Q4 2022, filed 2 Feb 2023.